Streetbeat News

Regulatory

SPY

The Federal Reserve's Loretta Mester announced her retirement effective June 30, 204 due to Fed rules. This may cause some changes in the Federal Reserve's policy stance.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 3:36 pm

SPY

The Federal Reserve Bank of Cleveland has initiated a search for its next President and CEO, as the term of the current President, Loretta Mester, is set to conclude on June 30, in line with the Fed's mandatory retirement policies.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 3:35 pm

MBOT

Microbot Medical Inc. (NASDAQ:MBOT) has been granted a registered trademark from the US Patent and Trademark Office for the feature 'One & Done' of the LIBERTY Robotic Surgical System. This system is being developed to integrate guidewires, microcatheters and other instruments required for complete endovascular procedures. The company continues to expand its proprietary assets, including numerous approved and pending patents worldwide.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:15 pm

SILO

Silo Pharma, Inc. (NASDAQ:SILO) has announced plans to initiate a dose-ranging study of its targeted prophylactic treatment SPC-15 for the treatment of post-traumatic stress disorder (PTSD). The study, in collaboration with AmplifyBio, will identify the maximum tolerated intranasal dose of the drug and pharmacokinetic in small animals. The final validation report is expected in 2024. If clinically successful, SPC-15 could qualify for the FDA's streamlined 505(b)(2) regulatory pathway for drug approval.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:11 pm

NDRA

Endra Life Sciences has announced the issuance of three new patents, one in the US and two in China. This expands Endra's intellectual property portfolio to 70 issued patents worldwide for the novel Taeus system.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:08 pm

GEHC

MASI

GE HealthCare (NASDAQ:GEHC) and Masimo (NASDAQ:MASI) have announced a collaboration to integrate Masimo's Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's Portrait Mobile wireless and wearable patient monitoring solution. The integration will allow clinicians to use Masimo's oxygen saturation measurement technology to noninvasively detect and monitor changes in patient status. The announcement follows the FDA clearance of Portrait Mobile in August 2023.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:02 pm

AAPL

DTEGF

GOOG

MSFT

VOD

Google, in partnership with several European telecom companies, is urging the European Commission to recognize Apple's iMessage as a 'core' service, which would force Apple to make iMessage interoperable with other messaging services. This comes amidst an ongoing EC investigation to determine if iMessage meets the stringent criteria to fall under the purview of the DMA. Apple and Microsoft have been lobbying to exempt their services from this designation.

Portfolio Pulse from Rounak Jain

November 08, 2023 | 12:52 pm

BTAI

Bioxcel Therapeutics has announced overall survival data from its Phase 2 trial of BXCL701 plus Keytruda for metastatic castration-resistant prostate cancer. The data showed a median overall survival of 15.5 months and a 12-month survival rate of 59%.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:19 pm

IMTX

Immatics has reported interim clinical data from its ongoing Phase 1 trial of ACTengine IMA203 and IMA203CD8 TCR-T monotherapies targeting PRAME. The company has not disclosed the specifics of the data.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:18 pm

BIOL

BIOLASE has reported findings from a 12-month follow-up to a clinical trial performed at The McGuire Institute. The study confirms that BIOLASE's Waterlase REPAIR® Perio protocol has similar and sustainable clinical outcomes as compared to traditional MIST in treating intrabony defects.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 11:35 am